Live Webinar ADVANCE ACS- ADVances in Antiplatelet maNagement and Clinical Evidence for ACS | 18 Aug 2022

Live Webinar

ADVANCE ACS

ADVances in Antiplatelet maNagement and Clinical Evidence for ACS

18^th August 2022 (Thursday)

5:00 PM - 6:40 PM

6:00 PM - 7:40 PM

This program is endorsed by

IMPORTANT INSTRUCTION: For easy access and better experience, please join the Webinar room (Adobe Connect) in the web-browser only from your Mobile phone/Tablet/Desktop/Laptop.

Important Guide for Webinar Attendees

Please download & install the free Webinar Platform app (Adobe Connect) from the link below to join the live webinar session.

Download links of Adobe Connect Application (as applicable to your device):
PC - Windows | Mac

Quick Start Guide:

Desktop/Laptop Users
Mobile/Tablet Users

If you are joining from mobile phone, please choose "Join via Browser" option for easy and better experience.

Test your device & connection: Prior to attending the webinar session, please test your connection and device from this link and ensure all steps get the check/right (✔) mark. Follow the on-page guides at the diagnostic page.

FACULTY OF THE PROGRAM

Moderator

Prof. Juan-Carlos Kaski

DSc, MD (Hons), FRCP, FESC, FACC, FAHA, FRSM Professor of Cardiovascular Science (Emeritus), St George’s, University of London

Prof. Juan-Carlos Kaski / DSc, MD (Hons), FRCP, FESC, FACC, FAHA, FRSM Professor of Cardiovascular Science (Emeritus), St George’s, University of London

Professor Juan-Carlos Kaski is an honorary consultant cardiologist at our diagnosticsand outpatient facility at 77 Wimpole Street, where he treats private patients.

He is Editor-in-Chief of European Cardiology Review Journal, Deputy Editor (IHD) of European Heart Journal and a member of the editorial board of over twenty major scientific journals, including the European Journal of Cardiology and the Journal of the American College of Cardiology, as well as immediate past associate editor of
Cardiovascular Drugs and Therapy.

Prof Kaski is Doctor Honoris Causa of the University of St Luis in Argentina and the University Carol Davila, Bucharest. He has received numerous scientific and educational awards, including the Gold Medal of the Spanish Society of Cardiology, Scientiae Magistri Award (Rome), RAICES award (Argentina) and Fukushima
University award (Japan), for his contribution to cardiovascular research and teaching.

Professor Kaski is Chairman-Elect of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the immediate past President and Chair of the Executive Board of the International Society of Pharmacotherapy, an affiliate member of the World Heart Federation.

Speakers

Prof. Carlo Di Mario

Professor of Cardiology, Careggi University Hospital, Florence,
Italy

Prof. Carlo Di Mario / Professor of Cardiology, Careggi University Hospital, Florence, Italy

Professor Carlo Di Mario is an honorary consultant cardiologist at Royal Brompton & Harefield Hospitals Specialist Care, where he treats private patients.

He studied medicine and cardiology at the University of Padova in Italy, his home country. He then completed his interventional training and PhD at the Erasmus University of Rotterdam, in the Netherlands. He went on to be the research and clinical director for interventional cardiology at the San Raffaele Hospital in Milan, Italy.

In 2003, Professor Di Mario took up a specialist post at Royal Brompton & Harefield NHS Foundation Trust. Alongside that role he was Professor of Clinical Cardiology at Imperial College London.

Since 2016, Professor Di Mario has been Chair of Cardiology at the University of Florence in Italy.

Prof. Dirk Sibbing

Professor of Cardiology and Angiology, Ludwig-Maximilians-University of Munich, Germany

Prof. Dirk Sibbing / Professor of Cardiology and Angiology, Ludwig-Maximilians-University of Munich, Germany

Dirk Sibbing, MD, FESC, MHBA is Professor of Cardiology and Angiologist, being affiliated with the Privatklink Lauterbacher Mühle and Ludwig-Maximilians University (LMU) in Munich. Prof. Sibbing trained and worked as fellow at the Deutsches Herzzentrum München from 2004-2012. From 2012-2019 he worked as senior doctor and interventional cardiologist at the department of cardiology at LMU Munich. From 2019 on he is affiliated with the Privatklinik Lauterbacher Mühle and LMU Munich. Prof. Sibbing contributed as active task force member to a number of national and international cardiology treatment guidelines (e.g. ESC 2020 guidelines on NSTE-ACS, ESC 2018 guidelines on myocardial revascularization) and he is listed among the 50 most frequently cited cardiovascular researchers in the German speaking area and has (co)-authored >160 articles with over 10,000 citations in peer- reviewed journals, including: NEJM, The Lancet, JACC, Circulation, European Heart Journal and Thrombosis & Haemostasis. Prof. Sibbing is the immediate past-chair of the ESC Thrombosis Working Group. His H-index is 42 and his main scientific interests are: antithrombotic drugs, antiplatelet drugs, platelet function, and genetics of cardiovascular disorders.

AGENDA

18^th August 2022

Welcome and Introduction – Prof. Juan-Carlos Kaski
Advances in the Diagnosis and Management of ACS and Unmet Needs – Prof. Carlo Di Mario
Individualised Anti-platelet Management in Clinical Practice – Prof. Dirk Sibbing

Panel Discussion – All
Closing Remarks- Prof. Juan-Carlos Kaski

Save your spot right now

Days

Hours

Minutes

Seconds